Plasmodium falciparumMutant Haplotype Infection during Pregnancy Associated with Reduced Birthweight, Tanzania
Adult
haplotype
Adolescent
Plasmodium falciparum
malaria
Gestational Age
Infectious and parasitic diseases
RC109-216
Polymorphism, Single Nucleotide
Tanzania
Young Adult
03 medical and health sciences
0302 clinical medicine
Pregnancy
Humans
Prospective Studies
Malaria, Falciparum
Alleles
drug resistance
Research
R
Pregnancy Outcome
Infant, Low Birth Weight
mutations
3. Good health
Tetrahydrofolate Dehydrogenase
Haplotypes
Pregnancy Complications, Parasitic
Mutation
Medicine
Female
pregnancy
DOI:
10.3201/eid1909.130133
Publication Date:
2013-06-26T18:33:29Z
AUTHORS (14)
ABSTRACT
Intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) is a key strategy in the control of pregnancy-associated malaria. However, this strategy is compromised by widespread drug resistance from single-nucleotide polymorphisms in the Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthetase genes. During September 2008-October 2010, we monitored a cohort of 924 pregnant women in an area of Tanzania with declining malaria transmission. P. falciparum parasites were genotyped, and the effect of infecting haplotypes on birthweight was assessed. Of the genotyped parasites, 9.3%, 46.3%, and 44.4% had quadruple or less, quintuple, and sextuple mutated haplotypes, respectively. Mutant haplotypes were unrelated to SP doses. Compared with infections with the less-mutated haplotypes, infections with the sextuple haplotype mutation were associated with lower (359 g) birthweights. Continued use of the suboptimal IPTp-SP regimen should be reevaluated, and alternative strategies (e.g., intermittent screening and treatment or intermittent treatment with safe and effective alternative drugs) should be evaluated.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (58)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....